Login
View our latest Newsletter here.
Join us for an informative webinar featuring a panel discussion on the latest treatments in breast cancer care. Through detailed case studies, our expert panel will explore the practical application of new therapies, such as the use of adjuvant olaparib and abemaciclib, discussing their benefits and challenges in real-world settings.
Healthcare professionals will gain valuable insights into current treatment options and patient management strategies, enhancing their ability to provide comprehensive care.
Don't miss this opportunity to stay at the forefront of breast cancer therapeutics.
Supported by an educational grant from Lilly
The Breast Multidisciplinary Team including surgeons, oncology trainees, allied health, breast care nurses and cancer care co-ordinators.
Case No.1
EBC - HR positive, HER2 negative with BRCA1 germline mutation
Adjuvant Abemaciclib or Olaparib?
Sanjeev Kumar
Case No.2
MBC – HR negative, HER2 low
What do you give second line? Sacituzumab Govitecan, TDxD, or something else?
Kathy You
Case No.3
MBC – TNBC PDL1 pos
The re-use of IO
Jen Gilchrist
Dr Sanjeev Kumar
Panel
A panel of multidisciplinary experts will participate during question times between each session and during the case studies session.
You will be emailed login details on Tuesday 15th October 2024.
* JOIN ASBD HERE prior to registering to access this and other courses free of charge.
Check ASBD Membership Benefits HERE